OrbusNeich Medical Group Holdings (FRA:Q8T) Scaled Net Operating Assets: 0.44 (As of Dec. 2025)


FRA:Q8T OrbusNeich Medical Group Holdings Ltd FRA:Q8T
96 GF Score
Price €0.37
GF Value €0.48
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings Scaled Net Operating Assets?

OrbusNeich Medical Group Holdings FRA:Q8T +2.20% 96 Scaled Net Operating Assets is 0.44 as of Dec. 2025. GuruFocus rates FRA:Q8T with a GF Score™ of 96/100 and a GF Value™ of €0.48. The stock has 2 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OrbusNeich Medical Group Holdings's operating assets for the quarter that ended in Dec. 2025 was €200.0 Mil. OrbusNeich Medical Group Holdings's operating liabilities for the quarter that ended in Dec. 2025 was €29.7 Mil. OrbusNeich Medical Group Holdings's Total Assets for the quarter that ended in Jun. 2025 was €386.5 Mil. Therefore, OrbusNeich Medical Group Holdings's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.44.


OrbusNeich Medical Group Holdings Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Scaled Net Operating Assets Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.78 0.31 0.34 0.38 0.41

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.33 0.37 0.37 0.44

FRA:Q8T vs ISRG, BDX, MDLN: Scaled Net Operating Assets Comparison

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's Scaled Net Operating Assets falls into.


FRA:Q8T
96GF Score
OrbusNeich Medical Group Holdings Ltd FRA:Q8T
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OrbusNeich Medical Group Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(200.012-29.718)/411.615
=0.41

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=386.785 - 186.773
=200.012

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=33.059 - 1.43 - 1.911
=29.718

OrbusNeich Medical Group Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Jun. 2025 )
=(200.012-29.718)/386.51
=0.44

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=386.785 - 186.773
=200.012

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=33.059 - 1.43 - 1.911
=29.718

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.44 mean?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Scaled Net Operating Assets of 0.44 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on OrbusNeich Medical Group Holdings and its competitors.
Is OrbusNeich Medical Group Holdings' Scaled Net Operating Assets too high?
OrbusNeich Medical Group Holdings' current Scaled Net Operating Assets is 0.44. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Scaled Net Operating Assets compare to ISRG and BDX?
OrbusNeich Medical Group Holdings' Scaled Net Operating Assets of 0.44 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on OrbusNeich Medical Group Holdings and its competitors. OrbusNeich Medical Group Holdings's current Scaled Net Operating Assets is 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Scaled Net Operating Assets of 0.44. The stock's GF Value™ is €0.48, compared to a current price of €0.37 — trading 22.5% below its estimated fair value. The current Scaled Net Operating Assets is 0.44. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Scaled Net Operating Assets is 0.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of €0.37 is trading 22.5% below its estimated GF Value™ of €0.48.

Key valuation signals for FRA:Q8T:

  • Scaled Net Operating Assets: 0.44
  • GF Value™: €0.48 vs. price of €0.37 (22.5% below fair value)
  • GF Score™: 96/100 with 2 warning signs

No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrbusNeich Medical Group Holdings Business Description

Other Exchanges 06929:Hong Kong
Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score

Get the complete analysis for FRA:Q8T

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€0.48
GF Value